Telephonic Disease Management Doesn’t Work …

If you have ever been at home cooking dinner with your family and received a call from the ‘disease management’ person at an insurance carrier, you likely understand why a purely telephonic approach to disease management simply doesn’t work.  There was a 2015 Harvard study which revealed that in fact a purely telephonic approach to disease management has zero effect on attempts at medical claims control.  Access article by clicking here.

Some of the reasons for this outcome include:

  • There is no relationship built between the plan member and the person on the other side of the phone line.
  • The call comes at random times in a non-scheduled manner.
  • Rarely will the call come from the same person, but rather multiple people depending upon who is working that particular day. This is particularly detrimental in that there is no relationship being built, and also it comes across as intrusive.
  • There is no accountability on the part of the plan member.

This approach stands in stark contrast to our one-on-one approach to disease management, which has measured effectiveness to deliver a return on investment.  Whether an employer chooses purely video based meetings between Sky nurses and their population, or in-person, they can be confident in our results since our process:

  • Focuses heavily on the relationship between the nurse and the high risk member.
  • We will ALWAYS use the same nurses month in and month out with your employee population. There simply is no other way to build relationships.
  • Our scheduled meetings are ALWAYS scheduled in advance, and normally during work hours. This again leads itself to building relationships, rather than being perceived as intrusive.
  • Accountability remains at the core of our approach, integrating any employer incentives to plan compliance which might be offered to employees (such as reduced copays or low/free copay drugs).

With nearly $2,000,000 spent to research the effectiveness of our methods, we can confidently say that our approach to disease management is the most intensively researched method in existence.  Here are a few studies that you might find particularly of interest:

  • Hypertension.  5 Year, 6200+ Patients.  Journal of American Pharmaceuticals Association.
    • 53% decrease in risk of cardiovascular event.
    • 50%+ reduction in risk of related cardiovascular emergency department visit.
    • 31% reduction in medical costs related to cardiovascular patients.
    • View External Research Article.
  • Diabetes Study.  5 Year, 200 Patients, Journal of American Pharmaceuticals Association.
    • Total direct medical cost decrease $1,200 to $1,872 per patient per year.
    • Estimated productivity increases estimated at $18,000 annually.
    • View External Research Article.
  • Asthma Study.  5 Year, 200+ Patients.  Journal of American Pharmaceuticals Association.
    • Total direct medical cost decrease $725 per patient per year.
    • Indirect cost savings estimation of $1,230 per patient per year.
    • View External Research Article.

 

Leave a Reply

Your email address will not be published. Required fields are marked *